Investment Management of Virginia’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-45,964
| Closed | -$2.47M | – | 181 |
|
|
2022
Q3 | $2.47M | Buy |
45,964
+1,112
| +2% | +$59.7K | 0.53% | 64 |
|
|
2022
Q2 | $2.5M | Sell |
44,852
-14,853
| -25% | -$827K | 0.51% | 69 |
|
|
2022
Q1 | $4.19M | Sell |
59,705
-12,036
| -17% | -$845K | 0.74% | 51 |
|
|
2021
Q4 | $6.91M | Sell |
71,741
-639
| -0.9% | -$61.6K | 1.11% | 24 |
|
|
2021
Q3 | $6.29M | Buy |
72,380
+5,695
| +9% | +$495K | 1.21% | 23 |
|
|
2021
Q2 | $5.46M | Sell |
66,685
-3,892
| -6% | -$319K | 1.05% | 27 |
|
|
2021
Q1 | $6.71M | Buy |
70,577
+16,726
| +31% | +$1.59M | 1.35% | 18 |
|
|
2020
Q4 | $3.34M | Buy |
53,851
+24,396
| +83% | +$1.51M | 0.73% | 45 |
|
|
2020
Q3 | $1.75M | Buy |
+29,455
| New | +$1.75M | 0.44% | 69 |
|